Learn more about the Registry
Alternatively, call the registry team toll-free at 1-877-390-2760 (hours of operation 8.30am - 5.00pm EST Monday-Friday)
You do not need to be on a weight loss medication to be eligible for this study.
Are you pregnant and diagnosed with obesity or have you taken Wegovy® (semaglutide) during pregnancy for the treatment of obesity?
Help future pregnant women, doctors, and researchers understand the safety of weight loss medication use during pregnancy.
Help future pregnant women, doctors, and researchers understand the safety of weight loss medication use during pregnancy.
Are you a healthcare provider who treats pregnant women with a diagnosis of either obesity or overweight with weight-related comorbidities?
Help us learn more about the safety of using Wegovy® (semaglutide) during pregnancy.
A pregnancy registry is a study that collects health information from pregnant women, including pregnant women on prescription medicines. Information is also collected on the newborn baby's health up to 1 year of age.
The goal of the Wegovy Pregnancy Registry is to help healthcare providers, patients, and researchers better understand the safety of Wegovy® (semaglutide) during pregnancy. Pregnant women in the United States with a diagnosis of either obesity or overweight may be eligible to participate regardless of whether they have taken Wegovy.
Alternatively, call the registry team toll-free at 1-877-390-2760 (hours of operation 8.30am - 5.00pm EST Monday-Friday)